How should I switch from fluoxetine 20 mg to bupropion (Wellbutrin)?

Switching from Fluoxetine 20 mg to Bupropion (Wellbutrin)

Stop fluoxetine 20 mg immediately and start bupropion SR 150 mg once daily in the morning after a 5-7 day washout period. This conservative approach minimizes the risk of drug interactions and allows fluoxetine's long half-life to clear sufficiently before initiating bupropion 1, 2.

Switching Strategy

Given fluoxetine's exceptionally long half-life (4-6 days for the parent compound, plus active metabolites lasting weeks), a direct cross-taper is unnecessary and potentially problematic 3. The recommended approach is:

Week 1: Washout Period

• Discontinue fluoxetine 20 mg completely
• Monitor for withdrawal symptoms (though fluoxetine's long half-life typically prevents significant discontinuation syndrome 3)
• Wait 5-7 days before starting bupropion

Week 2: Initiate Bupropion

• Start bupropion SR 150 mg once daily in the morning 1
• Take with or without food
• Avoid taking after 3 PM to minimize insomnia risk 3

Week 3-4: Titration

• If tolerated but insufficient response, increase to bupropion SR 150 mg twice daily (total 300 mg/day) 1
• Maximum dose is 300 mg/day for depression 3
• Second dose should be taken before 3 PM 3

Clinical Rationale

Bupropion is particularly effective for fluoxetine non-responders, with approximately 60% of SSRI-resistant patients achieving full or partial response when switched to bupropion 4. This makes it an evidence-based second-line choice. Additionally, bupropion offers significant advantages for patients experiencing SSRI-induced sexual dysfunction, with 94% showing complete or partial resolution of orgasm dysfunction after switching 5.

The conservative washout approach is preferred because:

• Fluoxetine's active metabolite (norfluoxetine) persists for 2-4 weeks after discontinuation 3
• Bupropion has a different mechanism (dopamine/norepinephrine reuptake inhibition vs. serotonin) 3, 6
• No risk of serotonin syndrome with this switch, but allowing clearance ensures clean pharmacology 2

Critical Safety Considerations

Contraindications for bupropion that must be screened:

• Seizure history or risk factors (stroke, brain metastases, eating disorders) - bupropion lowers seizure threshold 3, 7
• Current agitation or severe anxiety - bupropion is activating 3
• Concurrent MAOI use (requires 14-day separation) 1

Monitor for neuropsychiatric effects: Although uncommon, both fluoxetine and bupropion carry black box warnings for increased hostility, depression, or suicidal behavior, particularly during medication transitions 7. Close monitoring during the first 4-8 weeks is essential 8.

Alternative Rapid Switch (If Clinically Necessary)

If a 5-7 day washout poses unacceptable clinical risk due to severe depression, a more aggressive approach can be considered:

• Stop fluoxetine and start bupropion SR 150 mg the next day
• This carries minimal drug interaction risk since bupropion doesn't significantly affect serotonin 2
• However, this approach requires closer monitoring for symptom exacerbation during the transition

Expected Timeline

• Weeks 1-2: Fluoxetine effects wane, potential mild withdrawal (rare with fluoxetine)
• Weeks 2-4: Bupropion therapeutic effects begin to emerge
• Weeks 4-8: Full therapeutic trial to assess response 3, 1

Assess response at 4-6 weeks on the target dose of bupropion 300 mg/day. If inadequate response persists, consider alternative strategies such as augmentation or switching to a different class 8, 9.

Common Pitfalls to Avoid

• Don't attempt a cross-taper - fluoxetine's long half-life makes this unnecessary and complicates dosing
• Don't start bupropion at full dose - gradual titration minimizes seizure risk and tolerability issues 1
• Don't give the second bupropion dose late in the day - this commonly causes insomnia 3
• Don't assume immediate improvement - allow 4-8 weeks for full therapeutic assessment 3